Literature DB >> 20880090

Seroepidemiologic survey for Coxiella burnetii among hospitalized US troops deployed to Iraq.

A D Anderson1, T R Baker, A C Littrell, R L Mott, D W Niebuhr, B L Smoak.   

Abstract

Q fever is a zoonotic illness which frequently has a non-specific clinical presentation. Cases among deployed US military personnel have been reported in increasing numbers indicating an emerging at-risk occupational group. Banked serum specimens were utilized to estimate seroprevalence and risk factors among military personnel deployed to Iraq. Coxiella burnetii antibody testing was performed and epidemiologic data were analysed from 909 servicemembers. The overall number who seroconverted to Q fever was 88 (10%). The most common ICD-9 code assigned to Q fever cases was fever not otherwise specified (NOS) (45%). A combat occupational specialty was a risk factor for Q fever seroconversion (OR = 1.8, 95% CI: 1.1-2.8) as well as receiving a primary diagnosis of fever NOS (OR = 2.6, 95% CI: 1.6-4.1). These findings indicate that Q fever is a significant infectious disease threat to military personnel deployed to Iraq. A heightened awareness among physicians is necessary to ensure prompt diagnosis and treatment.
© 2010 Blackwell Verlag GmbH.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20880090     DOI: 10.1111/j.1863-2378.2010.01347.x

Source DB:  PubMed          Journal:  Zoonoses Public Health        ISSN: 1863-1959            Impact factor:   2.702


  13 in total

1.  Seroepidemiologic survey for Coxiella burnetii among US military personnel deployed to Southwest and Central Asia in 2005.

Authors:  Joseph Royal; Mark S Riddle; Emad Mohareb; Marshall R Monteville; Chad K Porter; Dennis J Faix
Journal:  Am J Trop Med Hyg       Date:  2013-09-16       Impact factor: 2.345

2.  Q Fever reporting: tip of the iceberg?

Authors:  Joshua D Hartzell
Journal:  Am J Trop Med Hyg       Date:  2014-11-17       Impact factor: 2.345

3.  Coxiella burnetii - Pathogenic Agent of Q (Query) Fever.

Authors:  Lutz Gürtler; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen
Journal:  Transfus Med Hemother       Date:  2013-12-23       Impact factor: 3.747

4.  Coxiella burnetii Antibody Prevalence and Risk Factors of Infection in the Human Population of Estonia.

Authors:  Kädi Neare; Marilin Janson; Pirje Hütt; Brian Lassen; Arvo Viltrop
Journal:  Microorganisms       Date:  2019-11-29

5.  Occupations at risk of contracting zoonoses of public health significance in Québec.

Authors:  Ariane Adam-Poupart; Laurie-Maude Drapeau; Sadjia Bekal; Geneviève Germain; Alejandra Irace-Cima; Marie-Pascale Sassine; Audrey Simon; Julio Soto; Karine Thivierge; France Tissot
Journal:  Can Commun Dis Rep       Date:  2021-01-29

6.  Q fever among culling workers, the Netherlands, 2009-2010.

Authors:  Jane Whelan; Barbara Schimmer; Peter Schneeberger; Jamie Meekelenkamp; Arnold Ijff; Wim van der Hoek; Mirna Robert-Du Ry van Beest Holle
Journal:  Emerg Infect Dis       Date:  2011-09       Impact factor: 6.883

Review 7.  Description and utilization of the United States department of defense serum repository: a review of published studies, 1985-2012.

Authors:  Christopher L Perdue; Angelia A Eick Cost; Mark V Rubertone; Luther E Lindler; Sharon L Ludwig
Journal:  PLoS One       Date:  2015-02-27       Impact factor: 3.240

8.  Vaccination against Q fever for biodefense and public health indications.

Authors:  Sara Ruiz; Daniel N Wolfe
Journal:  Front Microbiol       Date:  2014-12-16       Impact factor: 5.640

9.  Seroconversions for Coxiella and Rickettsial Pathogens among US Marines Deployed to Afghanistan, 2001-2010.

Authors:  Christina M Farris; Nhien Pho; Todd E Myers; Allen L Richards
Journal:  Emerg Infect Dis       Date:  2016-08       Impact factor: 6.883

10.  Standardized guinea pig model for Q fever vaccine reactogenicity.

Authors:  Laurie A Baeten; Brendan K Podell; Ann E Sluder; Anja Garritsen; Richard A Bowen; Mark C Poznansky
Journal:  PLoS One       Date:  2018-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.